Related Experiment Video
Updated: Jun 11, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Late Gadolinium Enhancement and Electrocardiographic Associations in Hypertrophic Cardiomyopathy
Issa Asfour1, Shahid Karim2,3, Sair A Tabraiz2
1East Tennessee State University, Johnson City, Tennessee, USA.
Insights
Late gadolinium enhancement (LGE) in hypertrophic cardiomyopathy (HCM) is linked to T-wave inversion on ECG but not precordial voltage. LGE did not increase atrial fibrillation risk in this adult study.
Area of Science:
- Cardiology
- Medical Imaging
- Electrophysiology
Background:
- Late gadolinium enhancement (LGE) via cardiovascular magnetic resonance (CMR) identifies myocardial fibrosis in hypertrophic cardiomyopathy (HCM).
- The relationship between LGE, electrocardiogram (ECG) abnormalities, and atrial fibrillation (AF) risk in adult HCM patients is not fully understood.
Purpose of the Study:
- To examine the association between LGE presence and extent with ECG characteristics.
- To assess the link between LGE and the incidence of AF in adults with HCM.
Main Methods:
- Retrospective cohort study of 144 adult HCM patients.
- CMR and 12-lead ECG data collected within 30 days.
- LGE quantified as % LV mass; categorized as absent, <5%, or ≥5%.
- ECG parameters analyzed, including QRS voltage and repolarization abnormalities.
- Median follow-up of 6.6 years for incident AF assessment.
Main Results:
- LGE present in 67% of patients; 22% had ≥5% LGE.
- No significant difference in precordial voltage across LGE groups.
- T-wave inversion more frequent in leads I, aVL, and V4 in patients with LGE.
- Patients with ≥5% LGE showed significantly lower LVEF.
- LGE presence was not associated with increased AF risk (HR 1.8, 95% CI 0.6-5.3).
Conclusions:
- In adult HCM, LGE correlates with specific ECG repolarization abnormalities, notably T-wave inversion in lateral leads.
- LGE does not significantly impact precordial voltage in adult HCM patients.
- Findings contrast with pediatric HCM, highlighting age-specific associations.
Background:
Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging is a well-established indicator of myocardial fibrosis in hypertrophic cardiomyopathy (HCM). However, its association with electrocardiographic (ECG) abnormalities and the risk of atrial fibrillation (AF) remains uncertain.
Objectives:
To investigate the association between the presence and burden of LGE with ECG characteristics, including precordial voltage, depolarization and repolarization abnormalities, and the incidence of AF in adults with HCM.
Methods:
We conducted a retrospective cohort study of 144 adults with HCM with CMR and 12-lead ECG within 30 days of each other. LGE was quantified as a percentage of LV mass and categorized as absent, < 5%, or ≥ 5%. ECG parameters, including QRS voltage, repolarization abnormalities, and LVH criteria, were analyzed. Incident AF was assessed during a median follow-up of 6.6 years.
Results:
LGE was present in 96 (67%) patients, with 21 (22%) having ≥ 5% LGE. There were no significant differences in precordial voltage between patients with and without LGE across Sokolow-Lyon, Cornell, and Romhilt-Estes criteria. However, T-wave inversion was more common in leads I (41% vs. 19%, p = 0.009), aVL (50% vs. 31%, p = 0.033), and V4 (41% vs. 23%, p = 0.035) in patients with LGE. Patients with ≥ 5% LGE had a significantly lower median LVEF (64% vs. 74%, p = 0.003). Additionally, LGE presence was not associated with an increased risk of incident AF (HR 1.8, 95% CI 0.6-5.3, p = 0.308).
Conclusion:
In contrast to pediatric HCM, LGE is associated with specific ECG repolarization abnormalities, particularly T-wave inversion in lateral leads, but does not significantly affect precordial voltage in adults.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
